Letter from Rick Doblin, MAPS President
Research Updates
New Research With MDMA to Look at Serotonin and Dopamine System Interactions
Manuel Tancer, M.D. & Charles R. Schuster, Ph.D.
Ketamine Research: From Yale to the Lab in St. Petersburg
Evgeny Krupitsky, M.D., Ph.D.
Israel: A Cognitive-Psychological Study of Ayahuasca
Benny Shanon, Ph.D.
Two new applications to NIH for research into the medical utility of marijuana
Abrams protocol submitted anew: Short-term effects of cannabinoids in HIV patients
Donald Abrams, M.D.
Cannabis in Acute Migraine Treatment Project
Ethan Russo, M.D.
Featured Articles
Treatment of Childhood Schizophrenia Utilizing LSD and Psilocybin
Gary Fisher, Ph.D.
Ethical Caring in Psychedelic Work
Kylea Taylor, M.S.
Hallucinogenic Drugs in Experimental Psychiatric Research Vaals, Netherlands – March 13-15, 1997
Julie Holland, M.D.
Comments by Sylvia Thyssen
The Hofmann Report
Myron Stolaroff, M.A.
The Heffter Research Institute Update
David E. Nichols, Ph.D.
Book Reviews
Non-Anglo Entheography: Mini-Reviews of Non-English Publications
Jonathan Ott
Searching for Magic Bullets: Orphan Drugs, Consumer Activism, and Pharmaceutical Development / Clinical Research in Pharmaceutical Development
Basara L R, and Montagne M. June Riedlinger, R.Ph., Pharm.D.
The Literature of Psychedelics
Bob Wallace
MAPS Forum
Hello from MAPS’ new staffperson
Carla Higdon
NIMH Researcher Studies Co-Administration of Antidepressants and Entheogens
Kit Bonson, Ph.D., NIMH
